Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Afamelanotide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Afamelanotide in fair-skinned Parkinson’s patients
    Afamelanotide in fair-skinned Parkinson’s patients

    17 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900070/0/en/Afamelanotide-in-fair-skinned-Parkinson-s-patients.html

    GLOBENEWSWIRE
    17 Jun 2024
    Share Share
    Positive final results in stroke
    Positive final results in stroke

    03 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/04/2435187/0/en/Positive-final-results-in-stroke.html

    GLOBENEWSWIRE
    03 May 2022
    Share Share
    Enforcement Report - Week of April 27, 2022
    Enforcement Report - Week of April 27, 2022

    27 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-27-2022-1651037135.pdf

    FDA
    27 Apr 2022
    Share Share
    Clinuvel enrolls in a world-first study of stroke
    Clinuvel enrolls in a world-first study of stroke

    18 Jan 2022

    // KALKINEMEDIA

    https://kalkinemedia.com/au/news/stock-market/clinuvel-enrolls-in-a-world-first-study-of-stroke

    KALKINEMEDIA
    18 Jan 2022
    Share Share
    CLINUVEL Expands Pharmaceutical Portfolio
    CLINUVEL Expands Pharmaceutical Portfolio

    07 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/08/2328862/0/en/CLINUVEL-Expands-Pharmaceutical-Portfolio.html

    GLOBENEWSWIRE
    07 Nov 2021
    Share Share
    First stroke patient treated with afamelanotide
    First stroke patient treated with afamelanotide

    07 Jun 2021

    // PRESS RELEASE

    https://www.clinuvel.com/first-stroke-patient-treated-with-afamelanotide/

    PRESS RELEASE
    07 Jun 2021
    Share Share